Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Larry A. Mole"'
Publikováno v:
Hepatology. 66:27-36
Reactivation of hepatitis B virus (HBV) has been reported in hepatitis C virus–infected individuals receiving direct-acting antiviral (DAA) therapy. The overall risk among patients with current or prior HBV infection in the context of DAA treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::849c87250faf832ed78d4e85f86c7da7
https://doi.org/10.1002/hep.29135
https://doi.org/10.1002/hep.29135
Autor:
Troy A. Shahoumian, Larry A. Mole, Lisa I. Backus, Debika Bhattacharya, Timothy P. Loomis, Pamela S. Belperio, Matthew Bidwell Goetz
Publikováno v:
Clinical Infectious Diseases. 64:1711-1720
Author(s): Bhattacharya, Debika; Belperio, Pamela S; Shahoumian, Troy A; Loomis, Timothy P; Goetz, Matthew B; Mole, Larry A; Backus, Lisa I | Abstract: Background.Large cohorts are needed to assess human immunodeficiency virus (HIV)/hepatitis C virus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17621b8c6d5514b58f10d077b362b6b5
https://doi.org/10.1093/cid/cix111
https://doi.org/10.1093/cid/cix111
Publikováno v:
Alimentary Pharmacology & Therapeutics. 44:400-410
Real-world data are needed to inform hepatitis C virus (HCV) treatment decisions.To assess the comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin (LDV/SOF ± RBV) vs. ombitasvir/paritaprevir/ritonavir + dasabuvir (OPrD) ± RBV in genotyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d602fa0fa130c25d6f75871f1af89bd
https://doi.org/10.1111/apt.13696
https://doi.org/10.1111/apt.13696
Publikováno v:
Hepatology. 64:405-414
Real-world effectiveness data are needed to inform hepatitis C virus (HCV) treatment decisions. The uptake of ledipasvir/sofosbuvir (LDV/SOF) regimens across health care settings has been rapid, but variations often occur in clinical practice. The ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab3511a356c524663dc8722fc9eae1fe
https://doi.org/10.1002/hep.28625
https://doi.org/10.1002/hep.28625
Publikováno v:
Journal of hepatology. 70(1)
Background & Aim Understanding the real-world effectiveness of all-oral hepatitis C virus (HCV) regimens informs treatment decisions. We evaluated the effectiveness of daclatasvir + sofosbuvir ± ribavirin (DCV + SOF ± RBV) and velpatasvir/sofosbuvi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c3435ccf3e63a4dfb1cd26f2e84307e
https://pubmed.ncbi.nlm.nih.gov/30266283
https://pubmed.ncbi.nlm.nih.gov/30266283
Publikováno v:
Alimentary Pharmacology & Therapeutics. 42:559-573
Real-world effectiveness data are needed to inform hepatitis C virus (HCV) treatment decisions.To assess sustained virological response (SVR) of sofosbuvir (SOF)-based regimens in routine medical practice.Observational, intent-to-treat cohort analysi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b4c99bce43f4a3f35971c4e90d610e7
https://doi.org/10.1111/apt.13300
https://doi.org/10.1111/apt.13300
Publikováno v:
Journal of Clinical Gastroenterology. 49:329-335
To examine the effect of provider type on outcomes and safety in a large hepatitis C virus (HCV)-infected cohort treated in routine medical practice.Nonphysician providers (NPP) are uniquely positioned to expand health care infrastructure to meet HCV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::682f18c0f8e48491c09db99c201ca3ef
https://doi.org/10.1097/mcg.0000000000000124
https://doi.org/10.1097/mcg.0000000000000124
Publikováno v:
Hepatology (Baltimore, Md.). 68(3)
The impact of sustained virologic response (SVR) on mortality after direct-acting antiviral (DAA) treatment is not well documented in patients without advanced liver disease and affects access to treatment. This study evaluated the impact of SVR achi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91bbfc6d5ac4d740d6d67f38bc6351df
https://pubmed.ncbi.nlm.nih.gov/29514390
https://pubmed.ncbi.nlm.nih.gov/29514390
Publikováno v:
Hepatology (Baltimore, Md.). 69(2)
The impact of sustained virologic response (SVR) on mortality after direct-acting antiviral treatment is not well documented. This study evaluated the impact of direct-acting antiviral-induced SVR on all-cause mortality and on incident hepatocellular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71b19e0c7b6b454ff4eeb699d6e1bfe0
https://pubmed.ncbi.nlm.nih.gov/28749564
https://pubmed.ncbi.nlm.nih.gov/28749564
Publikováno v:
Alimentary Pharmacology & Therapeutics. 39:93-103
Summary Background Limited data exist on the effectiveness of boceprevir and telaprevir in routine practice. Aim To assess the comparative effectiveness of boceprevir and telaprevir regimens. Methods In this observational, intent-to-treat cohort anal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76aaf6914e510ea1ce82e59002892321
https://doi.org/10.1111/apt.12546
https://doi.org/10.1111/apt.12546